Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 34.30B | 34.13B | 34.50B | 34.08B | 30.72B | 27.82B |
Gross Profit | 6.17B | 6.10B | 5.89B | 6.31B | 6.40B | 5.75B |
EBITDA | 3.22B | 2.86B | 3.49B | 3.69B | 4.04B | 3.46B |
Net Income | 1.22B | 1.07B | 1.26B | 1.33B | 1.72B | 1.33B |
Balance Sheet | ||||||
Total Assets | 73.61B | 72.34B | 73.61B | 70.63B | 69.23B | 65.24B |
Cash, Cash Equivalents and Short-Term Investments | 11.93B | 12.42B | 12.66B | 12.59B | 15.35B | 14.34B |
Total Debt | 3.78B | 3.26B | 4.14B | 5.93B | 5.98B | 5.77B |
Total Liabilities | 18.21B | 16.96B | 18.27B | 19.01B | 19.57B | 17.14B |
Stockholders Equity | 51.79B | 51.81B | 51.79B | 48.26B | 46.58B | 45.13B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 565.57M | 1.82B | -1.77B | 1.14B | 3.02B |
Operating Cash Flow | 0.00 | 2.37B | 3.01B | -344.14M | 2.08B | 4.49B |
Investing Cash Flow | 0.00 | -2.11B | -873.13M | -1.37B | -810.33M | -709.59M |
Financing Cash Flow | 0.00 | -1.60B | -2.34B | -582.56M | -227.94M | -1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥21.20B | 10.65 | 3.48% | 7.59% | 12.32% | ||
75 Outperform | ¥33.50B | 10.23 | 5.17% | 4.52% | 25.35% | ||
74 Outperform | ¥19.59B | 11.76 | 4.28% | 11.71% | 54.61% | ||
74 Outperform | ¥15.15B | 13.92 | 3.80% | -1.07% | -14.27% | ||
71 Outperform | ¥11.35B | 10.14 | 2.13% | 10.47% | 48.78% | ||
58 Neutral | HK$13.89B | 4.25 | -3.01% | 7.32% | 3.67% | -54.16% | |
45 Neutral | ¥14.00B | 17.68 | 5.80% | -7.91% | 46.90% |